These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 2975918)

  • 1. Measuring the serotonin uptake site using [3H]paroxetine--a new serotonin uptake inhibitor.
    Gleiter CH; Nutt DJ
    Adv Alcohol Subst Abuse; 1988; 7(3-4):107-11. PubMed ID: 2975918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoradiographic localization of 3H-paroxetine-labeled serotonin uptake sites in rat brain.
    De Souza EB; Kuyatt BL
    Synapse; 1987; 1(5):488-96. PubMed ID: 2975068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Characteristics of 3H-paroxetine-labeled serotonin uptake sites in rat brain].
    Yoshida Y
    Yakubutsu Seishin Kodo; 1988 Jun; 8(2):345-57. PubMed ID: 2975437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidepressant binding sites in brain: autoradiographic comparison of [3H]paroxetine and [3H]imipramine localization and relationship to serotonin transporter.
    Hrdina PD; Foy B; Hepner A; Summers RJ
    J Pharmacol Exp Ther; 1990 Jan; 252(1):410-8. PubMed ID: 2137177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeated electroconvulsive shock does not change [3H]-paroxetine binding to the 5-HT uptake site in rat cortical membranes.
    Gleiter CH; Nutt DJ
    Psychopharmacology (Berl); 1988; 95(1):68-70. PubMed ID: 2838861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors and the presynaptic 5-hydroxytryptamine inhibitory autoreceptors in the rat hypothalamus.
    Galzin AM; Moret C; Verzier B; Langer SZ
    J Pharmacol Exp Ther; 1985 Oct; 235(1):200-11. PubMed ID: 2864432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common binding site for tricyclic and nontricyclic 5-hydroxytryptamine uptake inhibitors at the substrate recognition site of the neuronal sodium-dependent 5-hydroxytryptamine transporter.
    Graham D; Esnaud H; Habert E; Langer SZ
    Biochem Pharmacol; 1989 Nov; 38(21):3819-26. PubMed ID: 2532013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [3H]tetrahydrotrazodone binding. Association with serotonin binding sites.
    Kendall DA; Taylor DP; Enna SJ
    Mol Pharmacol; 1983 May; 23(3):594-9. PubMed ID: 6865906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ; Largent BL; Snowman AM; Snyder SH
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical and pharmacological evaluation of the novel antidepressant and serotonin uptake inhibitor 2-(3,4-Dichlorobenzyl)-2-dimethylamino-1-propanol hydrochloride.
    Gouret CJ; Porsolt R; Wettstein JG; Puech A; Soulard C; Pascaud X; Junien JL
    Arzneimittelforschung; 1990 Jun; 40(6):633-40. PubMed ID: 2168703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [3H]paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region.
    Dewar KM; Reader TA; Grondin L; Descarries L
    Synapse; 1991 Sep; 9(1):14-26. PubMed ID: 1724575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3,4-Methylenedioxymethamphetamine and 3,4-methylenedioxyamphetamine destroy serotonin terminals in rat brain: quantification of neurodegeneration by measurement of [3H]paroxetine-labeled serotonin uptake sites.
    Battaglia G; Yeh SY; O'Hearn E; Molliver ME; Kuhar MJ; De Souza EB
    J Pharmacol Exp Ther; 1987 Sep; 242(3):911-6. PubMed ID: 2443644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of high-dose fenfluramine treatment on monoamine uptake sites in rat brain: assessment using quantitative autoradiography.
    Appel NM; Mitchell WM; Contrera JF; De Souza EB
    Synapse; 1990; 6(1):33-44. PubMed ID: 2144664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoradiography of antidepressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine.
    Cortés R; Soriano E; Pazos A; Probst A; Palacios JM
    Neuroscience; 1988 Nov; 27(2):473-96. PubMed ID: 2975361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo labeling of serotonin uptake sites with [3H]paroxetine.
    Scheffel U; Hartig PR
    J Neurochem; 1989 May; 52(5):1605-12. PubMed ID: 2523469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine, 3H-citalopram and 3H-imipramine.
    Plenge P; Mellerup ET; Laursen H
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(1):61-72. PubMed ID: 2137251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complex inhibition of [3H]imipramine binding by serotonin and nontricyclic serotonin uptake blockers.
    Sette M; Briley MS; Langer SZ
    J Neurochem; 1983 Mar; 40(3):622-8. PubMed ID: 6827265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regional and subcellular localization in human brain of [3H]paroxetine binding, a marker of serotonin uptake sites.
    Laruelle M; Vanisberg MA; Maloteaux JM
    Biol Psychiatry; 1988 Jul; 24(3):299-309. PubMed ID: 2969755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of [3H]paroxetine binding to the 5-hydroxytryptamine uptake site in an animal model of depression.
    Edwards E; Harkins K; Wright G; Henn F
    J Neurochem; 1991 May; 56(5):1581-6. PubMed ID: 1826517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localisation of tricyclic antidepressant binding sites on serotonin nerve terminals.
    Sette M; Raisman R; Briley M; Langer SZ
    J Neurochem; 1981 Jul; 37(1):40-2. PubMed ID: 7252512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.